Eagle Bay Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30
| Closed | -$72 | – | 993 |
|
|
2024
Q1 | $72 | Sell |
30
-39
| -57% | -$94 | ﹤0.01% | 967 |
|
|
2023
Q4 | $230 | Sell |
69
-5,164
| -99% | -$17.2K | ﹤0.01% | 815 |
|
|
2023
Q3 | $19.6K | Buy |
5,233
+3,729
| +248% | +$13.9K | 0.01% | 523 |
|
|
2023
Q2 | $6.42K | Sell |
1,504
-2,732
| -64% | -$11.7K | ﹤0.01% | 638 |
|
|
2023
Q1 | $29K | Buy |
4,236
+3,009
| +245% | +$20.6K | 0.02% | 484 |
|
|
2022
Q4 | $9.72K | Sell |
1,227
-2,775
| -69% | -$22K | 0.01% | 599 |
|
|
2022
Q3 | $39K | Buy |
4,002
+111
| +3% | +$1.08K | 0.02% | 388 |
|
|
2022
Q2 | $28.2K | Buy |
3,891
+2,243
| +136% | +$16.2K | 0.02% | 489 |
|
|
2022
Q1 | $21K | Sell |
1,648
-472
| -22% | -$6.02K | 0.02% | 225 |
|
|
2021
Q4 | $34K | Buy |
2,120
+354
| +20% | +$5.68K | 0.02% | 453 |
|
|
2021
Q3 | $28K | Sell |
1,766
-155
| -8% | -$2.46K | 0.02% | 511 |
|
|
2021
Q2 | $28K | Buy |
+1,921
| New | +$28K | 0.02% | 472 |
|